Advertisement
Screener

ImmuCell Corporation (ICCC) Increase (Decrease) in Accrued Salaries

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Increase (Decrease) in Accrued Salaries

ImmuCell Corporation (ICCC) reported Increase (Decrease) in Accrued Salaries of $32.57 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedSalaries · last filed 2017-11-13

  • ImmuCell Corporation increase (decrease) in accrued salaries for the quarter ending 2017-09-30 was $66.37K, a 11.09% decline year-over-year.
  • ImmuCell Corporation increase (decrease) in accrued salaries for the quarter ending 2017-06-30 was -$63.57K.
  • ImmuCell Corporation increase (decrease) in accrued salaries for the quarter ending 2017-03-31 was $29.77K.
  • ImmuCell Corporation increase (decrease) in accrued salaries for the quarter ending 2016-12-31 was $12.37K, a 88.57% decline year-over-year.
  • ImmuCell Corporation increase (decrease) in accrued salaries for fiscal 2016 was -$42.21K, a 143.29% decline from fiscal 2015.
  • ImmuCell Corporation increase (decrease) in accrued salaries for fiscal 2015 was $97.51K, a 39.57% increase from fiscal 2014.
  • ImmuCell Corporation increase (decrease) in accrued salaries for fiscal 2014 was $69.87K.
Period endIncrease (Decrease) in Accrued Salaries 3 monthIncrease (Decrease) in Accrued Salaries 6 monthIncrease (Decrease) in Accrued Salaries 9 monthIncrease (Decrease) in Accrued Salaries 12 month
2017-09-30$66.37K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$2.79K
derived: sum of 2 quarters · filed 2017-11-13
$32.57K
10-Q · filed 2017-11-13
$44.93K
derived: sum of 4 quarters · filed 2017-11-13
2017-06-30-$63.57K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$33.80K
10-Q · filed 2017-08-14
-$21.43K
derived: sum of 3 quarters · filed 2017-08-14
$53.21K
derived: sum of 4 quarters · filed 2017-08-14
2017-03-31$29.77K
10-Q · filed 2017-05-11
$42.14K
derived: sum of 2 quarters · filed 2017-05-11
$116.78K
derived: sum of 3 quarters · filed 2017-05-11
$56.69K
derived: sum of 4 quarters · filed 2017-05-11
2016-12-31$12.37K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30
$87.01K
derived: sum of 2 quarters · filed 2017-03-30
$26.91K
derived: sum of 3 quarters · filed 2017-03-30
-$42.21K
10-K · filed 2017-03-30
2016-09-30$74.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$14.55K
derived: sum of 2 quarters · filed 2016-11-10
-$54.58K
10-Q · filed 2016-11-10
$53.65K
derived: sum of 4 quarters · filed 2016-11-10
2016-06-30-$60.10K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
-$129.22K
10-Q · filed 2016-08-11
-$21.00K
derived: sum of 3 quarters · filed 2016-08-11
$29.84K
derived: sum of 4 quarters · filed 2016-08-11
2016-03-31-$69.13K
10-Q · filed 2016-05-11
$39.10K
derived: sum of 2 quarters · filed 2016-05-11
$89.93K
derived: sum of 3 quarters · filed 2016-05-11
$48.70K
derived: sum of 4 quarters · filed 2016-05-11
2015-12-31$108.22K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
$159.06K
derived: sum of 2 quarters · filed 2016-03-25
$117.82K
derived: sum of 3 quarters · filed 2016-03-25
$97.51K
10-K · filed 2016-03-25
2015-09-30$50.84K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$9.60K
derived: sum of 2 quarters · filed 2015-11-12
-$10.71K
10-Q · filed 2015-11-12
2015-06-30-$41.24K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
-$61.55K
10-Q · filed 2015-08-13
2015-03-31-$20.31K
10-Q · filed 2015-05-12
2014-12-31$69.87K
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92